Catheryne Chiang1, Lisa Gallicchio2, Howard Zacur3, Sue Miller3, Jodi A Flaws1, Rebecca L Smith4. 1. Department of Comparative Biosciences, University of Illinois College of Veterinary Medicine, 2001 S. Lincoln Ave, Urbana, IL, USA. 2. Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, 9000, Rockville Pike, Bethesda, MD, USA. 3. Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, 733 N Broadway, Baltimore, MD, USA. 4. Department of Pathobiology, University of Illinois College of Veterinary Medicine, 2001 S. Lincoln Ave, Urbana, IL, USA. Electronic address: rlsdvm@illinois.edu.
Abstract
OBJECTIVE: Hot flashes are believed to be related to hormonal changes. However, the relationship between hormonal fluctuations and hot flashes has not been studied. The objective of this study is to determine hormone measurement summaries that best explain the incidence of hot flashes in midlife women. STUDY DESIGN: In a cohort study of 798 midlife women over 1-7 years, women provided 4 weekly blood samples annually and completed a survey detailing life history, ongoing behaviors, and menopausal symptoms. Estradiol, progesterone, and testosterone were measured in all serum samples. Annual summary variables of each hormone were median, mean, maximum, minimum, variance, and range. The association of these values with hot flashes was assessed using multivariable logistic regression and Bayesian network analysis, controlling for smoking history and menopausal status. MAIN OUTCOME MEASURES: Hot flash incidence, severity, and frequency. RESULTS: For most outcomes, the best-fit model included progesterone variability; increased progesterone variance or range was correlated with decreased hot flash frequency (OR = 0.82, 95% CI = 0.74-0.91) and severity (OR = 0.82, 95% CI = 0.77-0.88). In the Bayesian network model, the maximum estradiol value was negatively correlated with many outcomes (OR for hot flashes = 0.68). Relationships between progesterone variability, maximum estradiol level, maximum progesterone level, and hot flashes indicate that the effects of progesterone variance on hot flash outcomes are likely mediated through progesterone's relationship with maximum estradiol level. CONCLUSIONS: Variability of progesterone, as opposed to mean values, should be used as an indicator of risk of hot flashes in midlife women.
OBJECTIVE:Hot flashes are believed to be related to hormonal changes. However, the relationship between hormonal fluctuations and hot flashes has not been studied. The objective of this study is to determine hormone measurement summaries that best explain the incidence of hot flashes in midlife women. STUDY DESIGN: In a cohort study of 798 midlife women over 1-7 years, women provided 4 weekly blood samples annually and completed a survey detailing life history, ongoing behaviors, and menopausal symptoms. Estradiol, progesterone, and testosterone were measured in all serum samples. Annual summary variables of each hormone were median, mean, maximum, minimum, variance, and range. The association of these values with hot flashes was assessed using multivariable logistic regression and Bayesian network analysis, controlling for smoking history and menopausal status. MAIN OUTCOME MEASURES: Hot flash incidence, severity, and frequency. RESULTS: For most outcomes, the best-fit model included progesterone variability; increased progesterone variance or range was correlated with decreased hot flash frequency (OR = 0.82, 95% CI = 0.74-0.91) and severity (OR = 0.82, 95% CI = 0.77-0.88). In the Bayesian network model, the maximum estradiol value was negatively correlated with many outcomes (OR for hot flashes = 0.68). Relationships between progesterone variability, maximum estradiol level, maximum progesterone level, and hot flashes indicate that the effects of progesterone variance on hot flash outcomes are likely mediated through progesterone's relationship with maximum estradiol level. CONCLUSIONS: Variability of progesterone, as opposed to mean values, should be used as an indicator of risk of hot flashes in midlife women.
Authors: Joyce T Bromberger; Laura L Schott; Howard M Kravitz; Maryfran Sowers; Nancy E Avis; Ellen B Gold; John F Randolph; Karen A Matthews Journal: Arch Gen Psychiatry Date: 2010-06
Authors: Pauline M Maki; Ellen W Freeman; Gail A Greendale; Victor W Henderson; Paul A Newhouse; Peter J Schmidt; Nelda F Scott; Carol A Shively; Claudio N Soares Journal: Menopause Date: 2010-07 Impact factor: 2.953
Authors: Lisa Gallicchio; Kala Visvanathan; Susan R Miller; Janice Babus; Lynn M Lewis; Howard Zacur; Jodi A Flaws Journal: Am J Obstet Gynecol Date: 2005-10 Impact factor: 8.661
Authors: Lisa Gallicchio; Susan R Miller; Judith Kiefer; Teresa Greene; Howard A Zacur; Jodi A Flaws Journal: Menopause Date: 2015-10 Impact factor: 2.953
Authors: Ayelet Ziv-Gal; Lisa Gallicchio; Catheryne Chiang; Sara N Ther; Susan R Miller; Howard A Zacur; Russell L Dills; Jodi A Flaws Journal: Reprod Toxicol Date: 2016-02-08 Impact factor: 3.143
Authors: Kala Visvanathan; Lisa Gallicchio; Chrissy Schilling; Janice K Babus; Lynn M Lewis; Susan R Miller; Howard Zacur; Jodi A Flaws Journal: Obstet Gynecol Date: 2005-12 Impact factor: 7.661
Authors: Jennifer L Gordon; David R Rubinow; Tory A Eisenlohr-Moul; Jane Leserman; Susan S Girdler Journal: Menopause Date: 2016-03 Impact factor: 2.953
Authors: Carolyn J Crandall; Joseph C Larson; Kristine E Ensrud; Andrea Z LaCroix; Katherine A Guthrie; Susan D Reed; Shalender Bhasin; Susan Diem Journal: Maturitas Date: 2022-04-25 Impact factor: 5.110
Authors: Brandi Patrice Smith; Esmeralda Cardoso-Mendoza; Jodi A Flaws; Zeynep Madak-Erdogan; Rebecca L Smith Journal: Womens Midlife Health Date: 2021-01-06